Driehaus Capital ARRY Position
ExitedDriehaus Capital exited their position in Array Technologies, Inc. (ARRY) in Q4 2023, after holding the stock for 2 quarters.
The position was first reported in Q3 2023 and has been tracked across 2 quarterly 13F filings.
Driehaus Capital ARRY Position History
Frequently Asked Questions
Does Driehaus Capital own ARRY?
No. Driehaus Capital exited their position in Array Technologies, Inc. (ARRY) in Q4 2023. They previously held the stock for 2 quarters.
How many hedge funds own ARRY?
Based on the 20 specialist biotech hedge funds tracked by BiotechEdge, no tracked fund currently holds an active position in ARRY.
When did Driehaus Capital first buy ARRY?
Driehaus Capital's position in ARRY was first reported in Q3 2023. 13F filings are reported with a 45-day delay, so the actual purchase may have occurred earlier in the quarter.
Is Driehaus Capital's ARRY position increasing or decreasing?
Driehaus Capital completely exited their ARRY position in the most recent quarter.
Get the weekly biotech signal briefing
Fund moves, convergence shifts, insider buys, and catalyst alerts — delivered free every Monday.
ARRYCompany Page →
All fund holders, insider trades, catalysts, and cash runway
Driehaus CapitalPortfolio →
Full 13F holdings, sector breakdown, and top movers
Drill into any signal
Fund Convergence
See which stocks multiple specialist funds are buying at once
Catalyst Calendar
Every PDUFA date, Phase 3 readout, and AdCom in one view
Insider Trading
When executives buy their own stock — the strongest bullish signal
Cash Runway
Which biotechs are running low on cash and face dilution risk
Short Squeeze
High short interest + fund buying + upcoming catalyst = squeeze setup
Signal Rankings
Every signal in one composite score — ranked by conviction
Biotech Movers
Stocks with the most signal activity right now across all signals
13F Changes
What top biotech funds bought and sold in the latest 13F filing
Want AI context on every signal? Start free trial →